Find articles of interest based on keywords and names, just click the most
popular links below to access the relevant articles.
The Clinical research facility is part of the NIHR and is funded by the Department of Health
Home > cll210
A Phase II Trial of Ofatumumab, Dexamethasone and Lenalidomide Followed by Randomisation to Lenalidomide Maintenance Versus No Further Treatment for High-Risk CLL.